These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3276481)

  • 21. The required beta cell research for improving treatment of type 2 diabetes.
    Thorens B
    J Intern Med; 2013 Sep; 274(3):203-14. PubMed ID: 23751050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early phase of insulin secretion after glucose stimulation in type II diabetes mellitus with hyper- and hypocalcemia].
    Gasińska T
    Pol Tyg Lek; 1983 Oct; 38(44):1357-60. PubMed ID: 6371742
    [No Abstract]   [Full Text] [Related]  

  • 23. The pathophysiologic defects of type 2 diabetes. Abnormal insulin action and impaired insulin secretion.
    Kahn SE
    Postgrad Med; 2000 May; 107(6 Suppl Key):11-5. PubMed ID: 19667505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
    Christensen MB
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus.
    Kruszynska YT; Olefsky JM
    J Investig Med; 1996 Oct; 44(8):413-28. PubMed ID: 8952222
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The physiology of glucagon-like peptide-1 and its role in the pathophysiology of type 2 diabetes mellitus].
    Escalada FJ
    Med Clin (Barc); 2014 Sep; 143 Suppl 2():2-7. PubMed ID: 25437458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Insulin secretion in diabetes mellitus].
    Deckert T
    Ugeskr Laeger; 1971 Oct; 133(43):2128. PubMed ID: 4941898
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-cell behavior during the prediabetic stage. Part I. Beta-cell pathophysiology.
    Homo-Delarche F
    Diabetes Metab; 1997 Jun; 23(3):181-94. PubMed ID: 9233994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroinflammatory and autonomic mechanisms in diabetes and hypertension.
    Han C; Rice MW; Cai D
    Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E32-41. PubMed ID: 27166279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relevance of glucose counterregulatory systems to patients with insulin-dependent diabetes mellitus.
    Cryer PE; White NH; Santiago JV
    Endocr Rev; 1986 May; 7(2):131-9. PubMed ID: 2873031
    [No Abstract]   [Full Text] [Related]  

  • 32. Post-prandial glycemic control: molecular targets for pharmacological intervention.
    Chandalia HB
    J Assoc Physicians India; 2001 Jan; 49 Spec No():11-6. PubMed ID: 11235597
    [No Abstract]   [Full Text] [Related]  

  • 33. Neural control of the endocrine pancreas.
    Woods SC; Porte D
    Physiol Rev; 1974 Jul; 54(3):596-619. PubMed ID: 4601624
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of stress in the etiology and treatment of diabetes mellitus.
    Surwit RS; Schneider MS
    Psychosom Med; 1993; 55(4):380-93. PubMed ID: 8105502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system and insulin secretion.
    Strubbe JH
    Neth J Med; 1989 Apr; 34(3-4):154-67. PubMed ID: 2657453
    [No Abstract]   [Full Text] [Related]  

  • 36. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.
    DeFronzo RA
    Diabetes; 1988 Jun; 37(6):667-87. PubMed ID: 3289989
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diabetes mellitus and endoplasmic reticulum stress].
    Araki E; Oyadomari S; Mori M
    Seikagaku; 2003 Oct; 75(10):1324-31. PubMed ID: 14635524
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeted glycemic control in type 2 diabetes.
    Skyler JS
    J Fla Med Assoc; 1998 Aug; 85(2):7-15. PubMed ID: 9782713
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of short-term hyperglycemia on insulin secretion in normal humans.
    Ferner RE; Ashworth L; Tronier B; Alberti KG
    Am J Physiol; 1986 Jun; 250(6 Pt 1):E655-61. PubMed ID: 3521312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice.
    Kvist-Reimer M; Sundler F; Ahrén B
    Cell Tissue Res; 2002 Feb; 307(2):203-9. PubMed ID: 11845327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.